Meeting
2019 Gastrointestinal Cancers Symposium
Local control following stereotactic body radiotherapy to adrenal oligometastases.
Authors
Nicholas B Figura
Moffitt Cancer Center, Tampa, FL
Nicholas B Figura , Daniel Eli Oliver , Peter Anthony Johnstone , Sarah E. Hoffe , Jessica Frakes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 447)
DOI
10.1200/JCO.2019.37.4_suppl.447
Abstract #
447
Poster Bd #
P7
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.
First Author: Yuanyuan Zhang
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial of combination of PD-1 immune checkpoint inhibition with all-lesion stereotactic radiation (SBRT) in oligometastatic renal cell carcinoma (omRCC).
First Author: Jing Liu
Poster
2023 ASCO Genitourinary Cancers Symposium
NRG-GU011: A phase II double-blinded, placebo-controlled trial of prostate oligometastatic radiotherapy with or without androgen deprivation therapy in oligometastatic prostate cancer (NRG PROMETHEAN).
First Author: Bridget F. Koontz
Poster
2019 ASCO Annual Meeting
NRG-BR002: A phase IIR/III trial of standard of care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer (NCT02364557).
First Author: Steven J. Chmura